Biojet has completed the consept study (FEL-2)
![Biojet has completed the consept study (FEL-2)](https://cdn.prod.website-files.com/6317496c7e9750ed2d8a67fa/64e49e4cc73f55d7923a7806_Forside%20FEL-2c%20rapport.jpg)
The consept study (FEL-2) of Biojet's technological platform has now been completed with satisfactory results regarding technical maturity, operational robustness, total yield/throughput and economical parameters. Biojet is proceeding with internal processes and seeking investors for the next project phase. (FEL-3)